MHA Today | March 6, 2018

March 6, 2018

MHA Today: News for Healthcare Leaders

twitter linkedin March 6, 2018

MHA Today is provided as a service to members of the Missouri Hospital Association. Additional information is available online at MHAnet.

In This Issue
House Approves Prescription Drug Take-Back Program
Committee Advances Bills To House Debate
Medicaid Imposes Limits On Opioid Prescriptions
CMS Announces MyHealthEData Initiative
Low Volume Appeals Settlement Option Update Call
SAMHSA Releases Publication Addressing Medications For Opioid Use Disorder
CMS Updates Data On IRF And LTCH Compare



Upcoming SEMINAR
Orientation for New Infection Prevention Professionals

Wednesday, May 2, and Thursday, May 3
Columbia Courtyard by Marriott
Columbia, Mo.

Register on or before Wednesday, April 18.


Advocate
state and federal health policy developments


House Approves Prescription Drug Take-Back Program

Staff Contact: Daniel Landon

The state House of Representatives gave its final approval to legislation authorizing broader opportunities for collecting and disposing of unused controlled substances. House Bill 1618 also directs the state Department of Health and Senior Services to develop an education campaign regarding the disposal of controlled substances and other drugs. It now moves to the Missouri Senate, which previously passed a similar bill. If enacted and signed into law, the bill would become effective immediately.

Back To Top


Committee Advances Bills To House Debate

Staff Contacts: Daniel Landon or Rob Monsees

A state House committee approved several health-related bills, allowing them to be placed in the queue for House debate. House Bill 2183 allows state hospital licensure regulations to update automatically to be in sync with Centers for Medicare & Medicaid Services’ standards and expands the definition of a hospital’s premises. House Bill 1574 and House Bill 2223 address collaborative practice arrangements and allow more flexibility in the number of APRNs and physician assistants a physician may supervise. House Bill 2280 would authorize Medicaid coverage for up to a year post-partum if the mother is receiving substance abuse treatment within 60 days of the birth.

Back To Top

 

Regulatory News
the latest actions of agencies monitoring health care


Medicaid Imposes Limits On Opioid Prescriptions

Staff Contacts: Daniel Landon or Brian Kinkade

Effective Tuesday, March 6, MO HealthNet is imposing new requirements for prescriptions of short-acting opioids and short-acting combination opioid drugs. Prescriptions for these drugs will require particular diagnoses, and edits will limit the allowable amounts (based on milligram morphine equivalents) and doses of drugs dispensed. Although pharmacists may be able to resolve some discrepancies through communication with the providers, prescriptions for patients without appropriate diagnoses will not be dispensed unless and until the prescribing provider submits the required clinical data to MO HealthNet.

Back To Top


CMS Announces MyHealthEData Initiative

Staff Contact: Andrew Wheeler

The Centers for Medicare & Medicaid Services announced a new initiative called MyHealthEData. The initiative is designed to empower patients by giving them control over their health care data. Led by the White House Office of American Innovation with participation from the Department of Health and Human Services, MyHealthEData also will help to “break down the barriers that prevent patients from having electronic access and true control of their own health records from the device or application of their choice.” CMS also announced the launch of Medicare’s Blue Button 2.0, which is a secure way for Medicare beneficiaries to access and share their personal health data in a universal digital format.

Back To Top


Low Volume Appeals Settlement Option Update Call

Staff Contact: Andrew Wheeler

The Centers for Medicare & Medicaid Services is hosting a low volume appeals settlement update call. CMS began accepting applications for settlement on Monday, Feb. 5. The settlement is for providers with fewer than 500 appeals pending at the Office of Medicare Hearing and Appeals and the Medicare Appeals Council, and the total billed amount is $9,000 or less per appeal. The call is scheduled for 12:30 p.m. Tuesday, March 13. Registration is required.

Back To Top

 

Quality and Population Health


SAMHSA Releases Publication Addressing Medications For Opioid Use Disorder

Staff Contacts: Leslie Porth or Shawn Billings

The Substance Abuse and Mental Health Services Administration updated protocols for providers regarding the use of the three Food and Drug Administration-approved medications used to treat opioid use disorder – buprenorphine, methadone and naltrexone – and the other strategies and services needed to support recovery.

Back To Top


CMS Updates Data On IRF And LTCH Compare

Staff Contact: Jim Mikes

The Centers for Medicare & Medicaid Services refreshed the websites for Inpatient Rehabilitation Facilities Compare and Long-Term Care Hospitals Compare. Results have been updated to include data submitted between second quarter 2016 and first quarter 2017.

Back To Top

 


Consider This ...

Emergency department visits for opioid overdoses rose 30 percent in all parts of the U.S. from July 2016 through September 2017. The Midwestern region witnessed an increase of 70 percent.

Source: Centers for Disease Control and Prevention